Clarivate Plc

  • Market Cap: Small Cap
  • Industry: Miscellaneous
  • ISIN: JE00BJJN4441
USD
3.76
0.01 (0.27%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

3.64 M

Shareholding (Mar 2025)

FII

31.14%

Held by 165 FIIs

DII

22.2%

Held by 96 DIIs

Promoter

26.61%

How big is Clarivate Plc?

22-Jun-2025

As of Jun 18, Clarivate Plc has a market capitalization of 2,896.29 million, with net sales of 2,529.20 million and a net profit of -665.60 million over the latest four quarters.

Market Cap: As of Jun 18, Clarivate Plc has a market capitalization of 2,896.29 million, categorizing it as a Mid Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Clarivate Plc reported net sales of 2,529.20 million and a net profit of -665.60 million.<BR><BR>Balance Sheet Snapshot: As of Dec'24, the company reported shareholder's funds of 5,139.00 million and total assets of 11,490.20 million.

Read More

What does Clarivate Plc do?

22-Jun-2025

Clarivate Plc is an information services and analytics company focused on scientific research, intellectual property, and life sciences, with recent net sales of $594 million and a market cap of approximately $2.9 billion. The company reported a net profit loss of $104 million for March 2025.

Overview:<BR>Clarivate Plc is an information services and analytics company serving the scientific research, intellectual property, and life sciences markets, operating within the miscellaneous industry and mid-cap bracket.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 594 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -104 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 2,896.29 Million (Mid Cap)<BR><BR>Key Metrics:<BR>Debt Equity: 0.83 <BR>Return on Equity: -1.79% <BR>Price to Book: 0.58 <BR><BR>Contact Details:<BR>Address: Friars House, 160 Blackfriars Road, LONDON PA: SE1 8EZ <BR>Tel: 44 20 74334000 <BR>Website: https://clarivate.com/

Read More

Is Clarivate Plc overvalued or undervalued?

20-Sep-2025

As of February 27, 2024, Clarivate Plc's valuation has shifted from fair to risky due to overvaluation indicators and significant underperformance compared to the S&P 500, with a year-to-date return of -19.09% and a three-year decline of 61.12%.

As of 27 February 2024, the valuation grade for Clarivate Plc has moved from fair to risky, indicating a significant deterioration in its investment appeal. The company appears to be overvalued based on its current metrics, with a Price to Book Value of 0.59, an EV to EBITDA of 7.46, and a ROCE of just 2.43%. In comparison to peers, Medpace Holdings, Inc. has a much higher P/E ratio of 33.13, while Genpact Ltd. stands at a fair valuation with a P/E of 14.38, highlighting Clarivate's relative weakness.<BR><BR>The stock has underperformed significantly against the S&P 500, with a year-to-date return of -19.09% compared to the index's 12.22%. Over the past three years, Clarivate's stock has declined by 61.12%, while the S&P 500 has gained 70.41%, reinforcing the notion that the company is struggling in the current market environment.

Read More

Is Clarivate Plc technically bullish or bearish?

07-Oct-2025

As of October 3, 2025, Clarivate Plc's technical trend is bearish, indicated by negative MACD, Bollinger Bands, and moving averages, with a year-to-date return of -25.20% compared to the S&P 500's 14.18%.

As of 3 October 2025, the technical trend for Clarivate Plc has changed from mildly bearish to bearish. The weekly MACD is bearish, and both the weekly and monthly Bollinger Bands indicate a bearish stance. Daily moving averages also confirm a bearish outlook. The KST is bearish on both weekly and monthly time frames, while the Dow Theory shows no trend in either time frame. <BR><BR>In terms of performance, Clarivate has underperformed the S&P 500 across multiple periods, with a year-to-date return of -25.20% compared to the S&P 500's 14.18%, and a one-year return of -42.60% versus 17.82% for the index. Overall, the current technical stance is bearish, reflecting a weak market position.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor Management Efficiency with a low ROCE of 1.63%

  • The company has been able to generate a Return on Capital Employed (avg) of 1.63% signifying low profitability per unit of total capital (equity and debt)
2

The company declared negative results in Mar'25 after flat results in Dec'24

3

Risky -

4

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

USD 3,012 Million (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.84

stock-summary
Return on Equity

-3.04%

stock-summary
Price to Book

0.60

Revenue and Profits:
Net Sales:
621 Million
(Quarterly Results - Jun 2025)
Net Profit:
-72 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-11.53%
0%
-11.53%
6 Months
-13.96%
0%
-13.96%
1 Year
-34.61%
0%
-34.61%
2 Years
-53.12%
0%
-53.12%
3 Years
-62.85%
0%
-62.85%
4 Years
-84.05%
0%
-84.05%
5 Years
-86.55%
0%
-86.55%

Clarivate Plc for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
19.83%
EBIT Growth (5y)
25.75%
EBIT to Interest (avg)
0.60
Debt to EBITDA (avg)
5.78
Net Debt to Equity (avg)
0.83
Sales to Capital Employed (avg)
0.25
Tax Ratio
14.98%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
1.63%
ROE (avg)
1.23%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.59
EV to EBIT
31.91
EV to EBITDA
7.46
EV to Capital Employed
0.77
EV to Sales
2.82
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
2.43%
ROE (Latest)
-1.79%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 62 Schemes (20.05%)

Foreign Institutions

Held by 165 Foreign Institutions (31.14%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 4.67% vs -10.45% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 30.70% vs 45.83% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "621.40",
          "val2": "593.70",
          "chgp": "4.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "236.70",
          "val2": "208.30",
          "chgp": "13.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "66.60",
          "val2": "64.30",
          "chgp": "3.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-9.30",
          "val2": "-24.70",
          "chgp": "62.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-72.00",
          "val2": "-103.90",
          "chgp": "30.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "73.70%",
          "val2": "38.60%",
          "chgp": "3.51%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -2.74% vs -1.17% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 30.13% vs 76.99% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,556.70",
          "val2": "2,628.80",
          "chgp": "-2.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "959.90",
          "val2": "982.70",
          "chgp": "-2.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "283.40",
          "val2": "293.70",
          "chgp": "-3.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-555.10",
          "val2": "-954.60",
          "chgp": "41.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-636.70",
          "val2": "-911.20",
          "chgp": "30.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "91.10%",
          "val2": "104.40%",
          "chgp": "-1.33%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
621.40
593.70
4.67%
Operating Profit (PBDIT) excl Other Income
236.70
208.30
13.63%
Interest
66.60
64.30
3.58%
Exceptional Items
-9.30
-24.70
62.35%
Consolidate Net Profit
-72.00
-103.90
30.70%
Operating Profit Margin (Excl OI)
73.70%
38.60%
3.51%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 4.67% vs -10.45% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 30.70% vs 45.83% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
2,556.70
2,628.80
-2.74%
Operating Profit (PBDIT) excl Other Income
959.90
982.70
-2.32%
Interest
283.40
293.70
-3.51%
Exceptional Items
-555.10
-954.60
41.85%
Consolidate Net Profit
-636.70
-911.20
30.13%
Operating Profit Margin (Excl OI)
91.10%
104.40%
-1.33%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -2.74% vs -1.17% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 30.13% vs 76.99% in Dec 2023

stock-summaryCompany CV
About Clarivate Plc stock-summary
stock-summary
Clarivate Plc
Miscellaneous
Clarivate PLC, formerly Clarivate Analytics Plc, is an information services and analytics company serving the scientific research, intellectual property and life sciences end-markets. The Company provides structured information and analytics to facilitate the discovery, protection and commercialization of scientific research, innovations and brands. The Company offers its products in two sub categories: Science group and Intellectual Property (IP) Group. Its product portfolio includes brands such as Web of Science, Derwent Innovation, Cortellis, CompuMark and MarkMonitor. The Company offers its structured information and analytical solutions to corporations, government agencies, universities, law firms and other professional services organizations worldwide.
Company Coordinates stock-summary
Company Details
Friars House, 160 Blackfriars Road , LONDON PA : SE1 8EZ
stock-summary
Tel: 44 20 74334000
stock-summary
Registrar Details